Tempus AI (NASDAQ:TEM) Shares Up 5.3% – Here’s What Happened

Posted by Brenda Bartman on Oct 28th, 2026

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) was up 5.3% during mid-day trading on Wednesday. The company traded as high as $75.21 and last traded at $75.9780. 609,567 shares changed hands during trading, a decline of 90% from the average session volume of 6,144,699 shares. The stock had previously closed at $72.15.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on TEM shares. Stifel Nicolaus cut their price target on shares of Tempus AI from $60.00 to $50.00 and set a “hold” rating for the company in a report on Monday, August 3rd. Wall Street Zen raised shares of Tempus AI from a “sell” rating to a “hold” rating in a research note on Saturday, July 25th. Rothschild & Co Redburn assumed coverage on shares of Tempus AI in a report on Tuesday, September 8th. They issued a “neutral” rating and a $67.00 price objective on the stock. UBS Group started coverage on shares of Tempus AI in a report on Wednesday, September 9th. They issued a “neutral” rating and a $70.00 target price on the stock. Finally, Weiss Ratings raised shares of Tempus AI from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, October 13th. Eleven equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $72.47.

View Our Latest Report on Tempus AI

Tempus AI Price Performance

The company’s 50-day moving average is $69.70 and its two-hundred day moving average is $56.95. The firm has a market cap of $13.82 billion, a P/E ratio of -53.09 and a beta of 3.54.

Tempus AI (NASDAQ:TEM – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.10. The company had revenue of $382.49 million for the quarter, compared to analyst estimates of $379.69 million. The firm’s quarterly revenue was up 21.6% on a year-over-year basis. During the same quarter last year, the company posted ($0.22) earnings per share. On average, analysts expect that Tempus AI, Inc. will post -1.43 EPS for the current fiscal year.

Insider Transactions at Tempus AI

In related news, CFO James Rogers sold 26,313 shares of the stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $60.00, for a total transaction of $1,578,780.00. Following the completion of the sale, the chief financial officer directly owned 106,024 shares of the company’s stock, valued at approximately $6,361,440. This trade represents a 19.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Eric P. Lefkofsky sold 250,000 shares of the stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $77.47, for a total value of $19,367,500.00. Following the transaction, the chief executive officer directly owned 100,000 shares of the company’s stock, valued at approximately $7,747,000. This trade represents a 71.43% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,030,965 shares of company stock valued at $69,882,564 in the last 90 days. 24.26% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Tempus AI

Large investors have recently made changes to their positions in the stock. China Universal Asset Management Co. Ltd. increased its position in shares of Tempus AI by 15.2% in the third quarter. China Universal Asset Management Co. Ltd. now owns 32,002 shares of the company’s stock worth $2,643,000 after purchasing an additional 4,227 shares during the last quarter. D.A. Davidson & CO. lifted its position in Tempus AI by 305.3% during the third quarter. D.A. Davidson & CO. now owns 21,522 shares of the company’s stock valued at $1,763,000 after purchasing an additional 16,212 shares during the last quarter. North Dakota State Investment Board bought a new stake in Tempus AI during the third quarter valued at approximately $270,000. Park Avenue Securities LLC purchased a new position in Tempus AI in the 3rd quarter worth approximately $214,000. Finally, Maxi Investments CY Ltd bought a new position in shares of Tempus AI in the 3rd quarter worth $2,662,000. 24.22% of the stock is owned by institutional investors.

Tempus AI Company Profile

(Get Free Report)

Tempus AI, Inc is a healthcare technology company that uses artificial intelligence and data analytics to support precision medicine. The company combines clinical, molecular and imaging data to help physicians make more informed treatment decisions and to help researchers and biopharmaceutical companies develop therapies.

Its offerings include genomic testing and analysis, such as tissue- and blood-based tests, as well as software tools designed to assist with clinical decision-making, patient matching for clinical trials and the management of healthcare data.